However, other studies report that miR-150-5p inhibits Wnt-β-catenin signaling via targeting GSKIP and HMGA2, or suppresses MMP14, or GLUT1 to exert its tumor-suppressive properties in NSCLC [24–26]. The gene discussed is HMGA2; the disease is neoplasm.